- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (56)
17 result(s) found for: Adh.
Displaying page 1 of 1.
EudraCT Number: 2004-005239-25 | Sponsor Protocol Number: CPR-SFY5904-EN-E01 | Start Date*: 2005-07-06 | |||||||||||
Sponsor Name:Sanofi-Synthelabo Research | |||||||||||||
Full Title: An open-label, multicenter study evaluating the long-term safety and efficacy of SR121463B in patients with Syndrome of Inappropriate Antidiuretic Hormone Secretion. | |||||||||||||
Medical condition: Syndrome of Inappropriate Antidiuretic Hormone (SIADH) with serum sodium between 115 and 132 mmol/L. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001169-33 | Sponsor Protocol Number: SAFA-1-2012 | Start Date*: 2012-07-02 | ||||||||||||||||
Sponsor Name:Department of Medical Research | ||||||||||||||||||
Full Title: Effects of tolvaptan on renal sodium and water handling and circulation during inhibition of the nitric oxide system in healthy subjects | ||||||||||||||||||
Medical condition: SIADH (Syndrome of inappropriate ADH production) Overhydration Hyponatrimia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003800-38 | Sponsor Protocol Number: SAFA-1-2014 | Start Date*: 2014-02-24 | ||||||||||||||||
Sponsor Name:Department of Medical Research | ||||||||||||||||||
Full Title: The effects of tolvaptan on renal handling of water and sodium, vasoactive hormones and circulatory system, during basal conditions and during inhibition of the nitric oxide system in healthy subj... | ||||||||||||||||||
Medical condition: Hyponatremia SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001973-15 | Sponsor Protocol Number: SAFA-2-2014 | Start Date*: 2014-11-18 | ||||||||||||||||
Sponsor Name:University Clinic in Nephrology and Hypertension, Department of Medical Research | ||||||||||||||||||
Full Title: Renal Handling of Water and Sodium in Autosomal Dominant Polycystic Kidney Disease. The effects of tolvaptan on renal handling of water and sodium , vasoactive hormones and central hemodynamics dur... | ||||||||||||||||||
Medical condition: Hyponatreamia SIADH ( Syndrome of Inappropriate Antidiuretic Hormone Secretion) Overhydration Autosomal dominant polycystic kidney disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005421-31 | Sponsor Protocol Number: | Start Date*: 2007-04-24 | |||||||||||
Sponsor Name:RER Saint Denis | |||||||||||||
Full Title: Effets hémodynamiques de l’administration de vasopressine au décours de l’Arrêt Cardio-Respiratoire chez des patients en état de choc réfractaire Hemodynamic effects of vasopressin administration i... | |||||||||||||
Medical condition: Patients admitted in ICU after sucessfully resuscitated cardiac arrest and developping a refractory shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003336-12 | Sponsor Protocol Number: FatherTrials2015 | Start Date*: 2016-03-23 | ||||||||||||||||
Sponsor Name:Universiteit Leiden | ||||||||||||||||||
Full Title: Father Trials: Hormonal Experiments on Prenatal and Postnatal Parenting | ||||||||||||||||||
Medical condition: There are no medical conditions or diseases under investigation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003488-22 | Sponsor Protocol Number: 10062003 | Start Date*: 2005-09-30 |
Sponsor Name:Charité CBF, Endokrinologie | ||
Full Title: Regulation des Antidiuretisches Hormons (ADH) und der antidiuretischen Wirkung unter Glucocorticoid - Therapie | ||
Medical condition: Es geht um keine therapeutische Fragestellung. In dem geplanten Versuch mit gesunden Probanden soll der Mechanismus der Wasser Resorption in der Niere trotz supprimiertem ADH nach Glukokortikoid Be... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004943-35 | Sponsor Protocol Number: 5122016 | Start Date*: 2017-03-01 |
Sponsor Name:Radboud University Medical Center | ||
Full Title: Stimulation of ADH independent urine concentration in healthy volunteers | ||
Medical condition: healthy volunteers; the information of this pilot study will be used in the care of patients with diabetes insipidus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022320-67 | Sponsor Protocol Number: 2010-022320-67 | Start Date*: 2010-10-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA | |||||||||||||
Full Title: USE OF TOLVAPTAN IN CLINICAL SYNDROMES CHARACTERIZED BY INAPPROPRIATE SECRETION OF ADH | |||||||||||||
Medical condition: hyponatremia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000500-29 | Sponsor Protocol Number: P150911 | Start Date*: 2016-06-03 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: A randomized Crossover TrIal to Compare recombinant human rhPTH(1-34) to the ASsociation alfacalcidol/hydrochlorothiazide in the treatment of Autosomal Dominant Hypocalcemia | |||||||||||||
Medical condition: Autosomal dominant hypocalcemia (ADH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001846-24 | Sponsor Protocol Number: 1 | Start Date*: 2016-06-29 |
Sponsor Name:Antwerp University Hospital | ||
Full Title: Metabolism of Isotonic versus Hypotonic Maintenance Solutions in fasting healthy Adults (MIHMoSA), a Single-Blind Randomized Crossover Trial | ||
Medical condition: Healthy adult volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004152-10 | Sponsor Protocol Number: EMPATHY | Start Date*: 2020-01-30 | ||||||||||||||||
Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI | ||||||||||||||||||
Full Title: Evaluating the Short-Term Renal and Systemic Effects of SGLT2 Inhibition in Non-Diabetic Patients at Risk of Accelerated GFR Decline Because of Glomerular Hyperfiltration: a sequential OFF-ON-OFF S... | ||||||||||||||||||
Medical condition: Obesity Renal chronic disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-002402-21 | Sponsor Protocol Number: RG_09-205 | Start Date*: 2007-08-24 | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate in reducing ototoxicity in patients receiving cisplatin chemotherapy for standard risk hepatoblastoma | |||||||||||||
Medical condition: Standard risk hepatoblatoma in children | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) FR (Ongoing) IE (Completed) ES (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017825-21 | Sponsor Protocol Number: EC09/081 | Start Date*: 2012-11-19 | |||||||||||
Sponsor Name:INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD | |||||||||||||
Full Title: Prospective, randomised, double-blind study to evaluate the efficacy of treatment with melatonin in adult patients with severe sepsis or septic shock. | |||||||||||||
Medical condition: Severe sepsis or septic shock. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003360-56 | Sponsor Protocol Number: 20050183 | Start Date*: 2009-08-28 | |||||||||||
Sponsor Name:Dept. of Pediatrics, The Childrens Hospital, Denver | |||||||||||||
Full Title: Farmakologisk behandling af CNDI – Et ”proof-of-concept” studie. | |||||||||||||
Medical condition: Kongenit nefrogen diabetes insipidus | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000134-34 | Sponsor Protocol Number: TEAM(B115UCS2019) | Start Date*: 2021-05-24 | |||||||||||
Sponsor Name:ENTE OSPEDALIERO OSPEDALI GALLIERA | |||||||||||||
Full Title: Time restricted Eating And Metformin (TEAM) in invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS). A randomized, phase IIb, window of opportunity presurgical trial. | |||||||||||||
Medical condition: Luminal (ER+ve and/or PgR+ve >=1%) invasive breast cancer not candidate to neo - adjuvant chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018961-50 | Sponsor Protocol Number: AMAG-FER-IDA-302 | Start Date*: 2010-07-02 | ||||||||||||||||
Sponsor Name:AMAG Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Phase III, Randomized, Open-label, Active-Controlled Trial Comparing Ferumoxytol with Iron Sucrose for the Treatment of Iron Deficiency Anemia | ||||||||||||||||||
Medical condition: iron deficiency anemia (IDA) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: LV (Completed) HU (Completed) FR (Completed) LT (Completed) DE (Completed) PL (Completed) GB (Completed) ES (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.